Back to School: How biopharma can reboot drug development. Access exclusive analysis here

PowderJect: Roche in a big hurry

Even though PowderJect Pharmaceuticals plc's needleless delivery system is jet-propelled, it was not fast enough for partner Roche. While Roche Group's decision to terminate a deal to develop a needleless injection version of an undisclosed protein led to speculation that

Read the full 403 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers